概要
本文首次报告了重症新型冠状病毒肺炎(COVID-19)感染接受肺移植并行急症冠脉介入治疗的病 例。通过对多学科协作成功救治的总结, 为重症 COVID-19 救治提供经验。我们发现, 重症 COVID-19 感染在肺移植术后可能出现多种危险 因素诱发心肌梗死, 急症冠脉介入治疗是救治此 类患者的重要手段。
Article PDF
References
Chen NS, Zhou M, Dong X, et al., 2020. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395(10223):507–513. https://doi.org/10.1016/S0140-6736(20)30211-7
Han YL, Zeng HS, Jiang H, et al., 2020. CSC expert consensus on principles of clinical management of patients with severe emergent cardiovascular diseases during the COVID- 19 epidemic. Circulation, in press. https://doi.org/10.1161/CIRCULATIONAHA.120.047011
Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
Peiris JSM, Chu CM, Cheng VCC, et al., 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet, 361(9371):1767–1772. https://doi.org/10.1016/S0140-6736(03)13412-5
Thygesen K, Alpert JS, Jaffe AS, et al., 2018. Fourth universal definition of myocardial infarction (2018). J Am College Cardiol, 72(18):2231–2264. https://doi.org/10.1016/j.jacc.2018.08.1038
Tsui KL, Leung TC, Yam LYC, et al., 2005. Coronary plague instability in severe acute respiratory syndrome. Int J Cardiol, 99(3):471–472. https://doi.org/10.1016/j.ijcard.2003.11.052
Wang DW, Hu B, Hu C, et al., 2020. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusinfected pneumonia in Wuhan, China. JAMA, 323(11): 1061–1069. https://doi.org/10.1001/jama.2020.1585
Wuhan Municipal Health Commission, 2020. Website of Wuhan Municipal Health Commission, Hubei, China. http://wjw.wuhan.gov.cn/front/web/showDetail/2020011609057 [Accessed on Mar. 26, 2020] (in Chinese).
Author information
Authors and Affiliations
Contributions
Tian-ming XUAN and Xiang-yuan PU reviewed literatures and prepared the first draft of the manuscript. Xing-xiang WANG, Wei-li HAN, and Xiao-gang GUO revised, edited, and checked the final version. All authors have read and approved the final manuscript and, therefore, have full access to all the data in the study and take responsibility for the integrity and security of the data.
Corresponding authors
Ethics declarations
Tian-ming XUAN, Xing-xiang WANG, Xiang-yuan PU, Wei-li HAN, and Xiao-gang GUO declare that they have no conflict of interest.
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008 (5). Informed consent was obtained from the patient for being included in the report.
Rights and permissions
About this article
Cite this article
Xuan, Tm., Wang, Xx., Pu, Xy. et al. Primary percutaneous coronary intervention in a COVID-19 patient with ST-segment elevation myocardial infarction after lung transplantation: a case report. J. Zhejiang Univ. Sci. B 21, 411–415 (2020). https://doi.org/10.1631/jzus.B2000182
Published:
Issue Date:
DOI: https://doi.org/10.1631/jzus.B2000182